Archives

  • Volume 5, Issue 1, Spring 2025

    • Emerging Biologics in the Management of Atopic Dermatitis
    • Updates in Epinephrine Guidelines
    • Use of the REMA Score to Distinguish Individuals with Systemic Mastocytosis From Those with Hereditary Alpha-tryptasemia
    • The Evolving Therapeutic Landscape for Hereditary Angioedema in Canada: Clinical Advances and Unmet Needs
    • An Update on Biologics in Pediatric Asthma: A Canadian Perspective

  • Special Supplement, Winter 2025

    • Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada

  • Volume 4, Issue 3, Fall 2024

    • A Practical Approach to NSAID Allergy David
    • Occupational Asthma Management
    • Treatment and Management of Chronic Cough in Children
    • Pearls from the 2024 European Respiratory Congress 
    • At-home Management of Food-induced Anaphylaxis

  • Volume 4, Issue 2, Summer 2024

    • Secondary Hypogammaglobulinemia
    • Understanding and Managing Adenotonsillar Hypertrophy in Pediatric Otolaryngology
    • Abstract Presentation Highlights from the 2024 EAACI Annual Meeting
    • Allergen Immunotherapy and Atopic Dermatitis: Updated Guidance
    • Pollen Cross-Reactivity: A Primer for Allergy Specialists

  • Volume 4, Issue 1, Spring 2024

    • Surgical Management of Allergic Rhinitis
    • Adult Obstructive Sleep Apnea: A Practical Guide for the Allergist
    • Shared Decision Making in Asthma Treatment: Using Motivational Communication to Elevate Your Consultations

  • Special Supplement, January 2024

    • Berotralstat: A data review of a novel oral medication for the treatment of hereditary angioedema

  • Special Supplement, January 2024

    • Atopic March and Disease Modification

  • Volume 3, Issue 3, December 2023

    • The use of IVIG for allergy consultants
    • Allergic conjunctivitiis: Treatment updates and long-term monitoring
    • Hydrogen and methane breath testing for abdominal bloating of small intestinal origin
    • Epinephrine auto-injectors in Canada: A review of available products and clinical proposals

  • Volume 3, Issue 2, August 2023

    • An Allergist's Approach to Eosinophilic Esophagitis
    • ANCA-Associated Vasculitis For the Allergist and Immunologist: A Clinical Update
    • Targeted Therapies for Allergic Conjunctivitis: An Ophthalmologist's Perspective
    • Aeroallergen Avoidance: Updated Evidence and How to Advise Patients
    • Adverse Reactions to Vaccines: An Allergist's Approach

  • Volume 3, Issue 1, May 2023

    • When Pruritus is Not Allergy: Appropriate Signs of Lymphoma and Other Malignancies for the Community Allergist
    • Abstract Presentation Highlights From the 2023 AAAAI Annual Meeting
    • Management of Hereditary Angioedema Type 1 and 2 for Canadian Allergy and Immunology Practitioners
    • Severe Asthma Phenotypes: Challenges and Options for Control
    • Food Allergy and Pediatric Nutrition: Understanding Replacement Needs for the Community Allergist

  • Special Supplement, May 2023

    • Assessment of Measurement-Based Care to Improve Outcomes in Patients with Allergic Rhinitis in an Open-Label, Prospective Study

  • Volume 2, Issue 3, December 2022

    • Systemic Management of Atopic Dermatitis: New and Emerging Therapies
    • Current Pharmacological and Non-Pharmacological Therapies for Chronic Cough
    • Atopic Dermatitis and Canadian Indigenous Peoples: Burdens, Barriers, and Potential for Solutions
    • Identifying Dermatological Emergencies in Out-Patient Care: When to be Worried

  • Special Supplement, November 2022

    • The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD

  • Volume 2, Issue 2, July 2022

    • Understanding, Preventing and Managing Food Allergy in Preschool Children: Part 1
    • The Use of Biologics in Food Therapy
    • Hypereosinophilia: A Guideline for Workup in the Allergy Community
    • An Overview of Cannabis Allergy

  • Special Supplement, May 2022

    • Future of Allergic Rhinitis Management: A Synopsis

  • Volume 2, Issue 1, April 2022

    • Component-Driven Oral Food Challenges in the Community
    • A New Era: Exploring the Role of Monoclonal Antibody Therapy in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
    • Asthma and Pregnancy: When You Have to Think of Two (Or More) Instead of One

  • Special Supplement, March 2022

    • Mast Cells in Atopic Diseases: More Than Just Histamine

  • Volume 1, Issue 3, December 2021

    • An Update on Select Topics in Chronic Rhinosinusitis With Nasal Polyps
    • Medical Management of Nasal Polyps
    • The Medical Management of Eosinophilic Esophagitis
    • Primary Ciliary Dyskinesia: A Review
    • Allergen Immunotherapy for the Control of Allergic Rhinoconjunctivitis

  • Special Supplement, November 2021

    • Similarities, Emerging Therapies, and the Burden of T Help Type 2 Diseases

  • Special Supplement, June 2021

    • Novel Topical Intranasal Therapies in the Management of Allergic Rhinitis

  • Volume 1, Issue 2, June 2021

    • Mast Cell Disorders: Overview, Clinical Pearls and Perspectives
    • Itching to Know More: Overcoming Barriers to Successful Management of Atopic Dermatitis
    • Treatment of Anaphylaxis and Modifications During Covid-19
    • Insect Sting Hypersensitivity
    • Amoxicillin Allergy: Old Concepts, New Concepts and Change of Concepts

  • Special Supplement, March 2021

    • Management of Chronic Urticaria and Itch: Beyond Histamine Blockade: The Importance of Platelet Activating Factor in Urticaria and its Treatment

  • Volume 1, Issue 1, March 2021

    • Asthma Management: A Review of GINA Recommendations from 2019
    • Bradykinin Mediated Angioedema
    • Oral Immunotherapy: An Overview of Key Studies
    • Antihistamines in CSU: Practice Points
    • Food Reintroduction in FPIES

  • Special Supplement, February 2021

    • Overview of the 2019 Allergic Rhinitis and its Impact on Asthma (ARIA) Next-Generation Update